Cancer patients would likely be among those most affected by a proposed rule tying certain Medicare Part B drug reimbursement rates to that of foreign countries.

Congress approved an FY 2021 funding deal that includes an increase for biomedical research funding at the National Institutes of Health (NIH) and cancer research at the National Cancer Institute (NCI).

The U.S. Senate passed legislation tonight aimed at improving access to clinical trials for communities of color and decreasing health disparities.